Jump to main content
Jump to site search

Issue 33, 2012
Previous Article Next Article

Targeting carbon nanotubes against cancer

Author affiliations

Abstract

The use of carbon nanotubes (CNTs) as polyvalent tools for cancer treatment is progressing at a very fast pace. The most promising approach is the targeted delivery of drugs, designed to selectively direct the therapeutic treatment towards the tumours. CNTs may offer several advantages to overcome one of the main limitations of most existing anticancer therapies, namely the lack of selectivity. Herein, an account of the existing literature on CNT-based nanomedicine for cancer treatment is given. The most significant results obtained so far in the field of drug delivery are presented for many anticancer chemotherapeutics (doxorubicin, methotrexate, taxanes, platinum analogues, camptothecine and gemcitabine), but also for immunotherapeutics and nucleic acids. Moreover, the alternative anticancer therapies based on thermal ablation and radiotherapy are discussed. The attention throughout the review is focused on the different targeting strategies proposed so far, mainly based on antibodies, but also on other specifically recognised molecules or on the application of an external magnetic field.

Graphical abstract: Targeting carbon nanotubes against cancer

Back to tab navigation

Publication details

The article was received on 21 Dec 2011, accepted on 20 Feb 2012 and first published on 21 Feb 2012


Article type: Feature Article
DOI: 10.1039/C2CC17995D
Chem. Commun., 2012,48, 3911-3926

  •   Request permissions

    Targeting carbon nanotubes against cancer

    C. Fabbro, H. Ali-Boucetta, T. D. Ros, K. Kostarelos, A. Bianco and M. Prato, Chem. Commun., 2012, 48, 3911
    DOI: 10.1039/C2CC17995D

Search articles by author

Spotlight

Advertisements